COMPANY PROFILE

OZiva

Explore full profile

India's Leading Clean, Plant based Nutrition Brand

Mumbai, IndiaFounded 2016Food

Valuation $50–100M Last recorded · 2026

Headcount 100–500 Current team size

Total funding $100–500M Disclosed equity funding

Unlock exact values

About OZiva

OZiva is a leading provider of clean, plant-based nutrition products in India, integrating modern science with ancient Ayurveda to promote an active and healthy lifestyle. The company offers a wide range of products including protein powders, superfoods, biotin supplements, and specialized nutrition for women, men, and children. OZiva's target market includes health-conscious individuals looking for natural and effective nutritional solutions. The business operates primarily through its online platform, oziva.in, where customers can purchase products directly. OZiva generates revenue through the sale of its nutrition products and related merchandise such as shakers and gym tote bags. The company also offers personalized diet plans and fitness guidance through its 'Fitness Kundali' service, enhancing customer engagement and loyalty.

MoreLess Source: Dealroom company data

At a glance

Status: Acquired
Founded: 2016
Headquarters: Mumbai, India
Employees: 216
Open positions: 3
Dealroom signal: 78.2/100
Industry: Wellness Beauty, Food
Sector: Food, Biotechnology, Biotech and Pharma, Hard Tech, Woman Founder, proteomics
Business model: Manufacturing
Client focus: b2c
Links: Website LinkedIn X

Knowledge graph

News, research, reports and resources connected to this company by Dealroom

Funding history

4 recorded events

Company financing events and reported valuations.

Deal type	Date	Amount	Valuation	Investors	Source
GROWTH EQUITY VCOther financing	Feb 2026	$91M	—	Hindustan Unilever	↗
ACQUISITIONOther financing	Dec 2022	$8.5M	—	Unilever	↗

Showing the latest 2 of 4 recorded eventsBook a demo for the full funding history →

Growth signals

OZiva website traffic

Latest recorded traffic for OZiva is 1.6M monthly website visits, up 64.9% over the last three months. OZiva's team grew 27.1% over the past year.

Latest monthly visits1.6M 3-month web change+64.9% 1-year team growth+27.1%

Monthly website visitsJun 2020–Jul 2026

Explore monthly traffic historyTrack growth over time and compare with peersBook a demo

Summary metrics are public; monthly history is available with a demoCompare with peers →

Open positions

Openings linked to this company in Dealroom

D2C Manager400093 Mumbai, India · Project Management · Sep 11, 2026 Category Manager400093 Mumbai, India · Marketing & Communication · Aug 26, 2026 Graphic DesignerMumbai, Maharashtra, India · Design · Jul 10, 2026 Copywriter400093 Mumbai, India · Other · Jul 6, 2026 Quality Control AssociateMumbai, Maharashtra, India · Other · Jun 21, 2026

5 distinct openings shownExplore hiring signals →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Company	Headquarters	Status	Employees	Total funding	Valuation
CBCube BiotechDeveloping solutions to improve lives and create greener agriculture	Monheim am Rhein, Germany	Acquired	59	—	—
SPSpyBiotechNovel vaccine platform using protein superglue technology	Oxford, United Kingdom	Operational
CTCongruence TherapeuticsBuilding the leading pharmacological stabilizer company for the treatment of rare diseases	Montreal, Canada	Operational
BEBetterOmicsAn AI cloud for omics data analysis, providing a centralized platform for reproducible validation, data traceability, and AI-powered insights, and featuring secure clinical-grade security and GxP compliance	Menlo Park, United States	Operational
LELeadartisA company developing bispecific tumor targeted antibodies based on its highly innovative protein engineering platform Trimerbody®	Tres Cantos, Spain	Operational
DIDiag-NoseWe use AI and protein signatures to help the one billion chronic respiratory patients worldwide find the right treatment, faster, so they can breathe better and live longer	Melbourne, Australia	Operational
AUAugurixAugurix design and market companion diagnostics devices to facilitate early diagnosis and confirmation of gastro-intestinal diseases	Monthey, Switzerland	Closed
PEPeptomycFoundational anti-MYC mini-proteins for cancer treatment	Barcelona, Spain	Operational